|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Pulmonary, Allergy, and Critical Care Medicine (Dr. Minai), Cleveland Clinic, Cleveland, OH; Genomic Medicine Institute (Ms. Rigelsky), Lerner Research Institute, Cleveland, OH; Cleveland Clinic Genomic Medicine Institute (Dr. Eng), Cleveland, OH; Division of Pulmonary, Critical Care, and Sleep Medicine (Dr. Arroliga), Scott and White Clinic, Temple, TX; and Cleveland Clinic Lerner College of Medicine (Dr. Stoller), Cleveland Clinic, Cleveland, OH.
Correspondence to: Omar A. Minai, MD, FCCP, Department of Pulmonary, Allergy, and Critical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195; e-mail: minaio{at}ccf.org
Abstract
Hereditary hemorrhagic telangiectasia (HHT) may be associated with pulmonary hypertension (PH). In the context that little attention has been given to long-term follow-up of such individuals, we report a patient with PH associated with HHT with special attention to clinical features and long-term response to therapy. To our knowledge, this case represents only the second with a 10-year follow-up reported and demonstrates that aggressive therapy can lead to long-term improvement in clinical parameters and survival.
Key Words: genetic hereditary hemorrhagic telangiectasia pulmonary hypertension pulmonary vascular disease shunt
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |